Capital Fund Management »

Intra Cellular Therapies shares owned by Capital Fund Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Capital Fund Management from 13F filings

Historical chart of Capital Fund Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Capital Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Capital Fund Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.1M 38k 83.52
2024-09-30 $1.9M 26k 73.17

More positions owned by Capital Fund Management

Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Netflix (NFLX)
Micron Technology (MU)
Microsoft Corporation (MSFT)
Palantir Technologies Cl A Call Option (PLTR)
Vaneck Etf Trust Gold Miners Etf (GDX)
JPMorgan Chase & Co. (JPM)
Costco Wholesale Corporation (COST)
Broadcom Call Option (AVGO)
Coinbase Global Com Cl A (COIN)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Capital Fund Management

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies